icometrix is an innovative company that brings quantitative brain MRI biomarkers from research to the patient, using advanced image processing algorithms. Its expertise in research and clinical trials has contributed to the development of accurate, reproducible and sensitive MRI biomarkers for the monitoring of neurodegenerative diseases in clinical routine. icometrix is currently active in three markets: advanced image processing (artificial intelligence) for 1) clinical studies, typically for (academic) researchers, 2) clinical trials for pharmaceutical and biotech companies and 3) clinical routine for neurologists and radiologists.